Ovu-Mate Oral
Strategic Reproductive Management for Mares – Made Easy
Simplify and optimize your mare's breeding cycle with Ovu-Mate Oral, a veterinarian-recommended, orally administered solution containing altrenogest (2.2 mg/mL). Designed to regulate estrus, reduce stress, and support reproductive success, this easy-to-use formulation empowers breeders and handlers with precise control over their mare’s hormonal cycle.
Key Benefits
✅ Regulates Estrus Cycles
✅ Stimulates Early-Season Ovulation
✅ Suppresses Disruptive Heat Behavior
✅ Supports Pregnancy Maintenance
✅ Reduces Stress During Travel or Events
Product Overview
-
Active Ingredient: Altrenogest (2.2 mg/mL)
-
Form: Oral solution
-
Mechanism of Action: Mimics the effects of natural progesterone to delay or suppress estrus, while promoting hormonal stability for controlled breeding.
Ideal For:
-
Planned Breeding Cycles: Align estrus with optimal timing based on competition, climate, or stallion access.
-
Early Breeding Season: Stimulates ovulation when follicular activity begins early in the year.
-
Calmer Training and Handling: Helps eliminate heat-related distractions and behavior.
-
Competition & Travel Management: Maintains emotional stability in high-stress environments.
-
Pregnancy Support: Aids mares with a history of early pregnancy loss or hormonal imbalance.
Easy Administration
-
Route: Oral (by syringe or feed-top dressing)
-
By: Veterinarian or trained handler, under veterinary guidance
-
Frequency & Duration: Based on individual assessment and goals—always follow veterinary direction.
Safe & Reversible
When Ovu-Mate Oral is discontinued, the mare’s natural cycle resumes, ensuring flexibility for future breeding or natural hormonal balance.
Storage Instructions
Store in a cool, dry place, away from direct sunlight. Always reseal after use and keep out of reach of children or other animals.
Veterinary-Directed Breeding Success
Ovu-Mate Oral is a trusted tool for effective cycle control, whether your goal is early-season breeding, behavior management, or improved conception rates.
Altrenogest 2.2 mg/mL in a vegetable oil solution